Shun Hamanaka   Taro Kishi   Kenji Sakuma   Yasufumi Nishii   Masakazu Hatano   Nakao Iwata   
Journal of psychiatric research 167 132-138 2023年10月
The benefits of serotonin 3 receptor antagonists (5-HT3R-As) in obsessive-compulsive disorder (OCD) treatment remain unclear. Thus, this study aimed to perform a systematic review and a random-effects meta-analysis, including double-blind, randomi...